Prelimary studies on metformin activation of AMPK to make cisplatin induce hepatocellular carcinoma cells apoptosis

ZHANG Yang-de,WANG Ning,LIAO Ming-mei,CHEN Yu-xiang
2013-01-01
Abstract:【Objective】 To investigate the effect of metformin combined with cisplatin(DDP) on the hepatocellular carcinoma cells.【Methods】 The effect of metformin combined DDP on the growth of human hepatic carcinoma cell line HepG2,SMMC7721 in vitro was evaluated by MTT assay.The Morphological changes of nucleus of HepG2 were evaluated by Hoechst33258 staining.The expression of AMPK/p-AMPK was evaluated by Western blot.【Results】 With the time and dosage increasing of metformin,cisplatin alone or combination,the inhibition for HepG2 and SMMC7721 was more effective.Cell apoptosis was the most apparent in combination group by Hoechst33258.AMPK was activated by metformin,cisplatin alone or combination,the upregulation of p-AMPK in the combination group was the most obvious.【Conclusion】 Metformin combined cisplatin can activate AMPK to increase the cytotoxicity for tumor cell.
What problem does this paper attempt to address?